Extracorporeal Membrane Oxygenation Rescue Therapy in a Case of Portopulmonary Hypertension During Liver Transplantation: A Case Report

被引:25
|
作者
Stratta, C. [1 ]
Lavezzo, B. [1 ]
Ballaris, M. A. [1 ]
Panio, A. [1 ]
Crucitti, M. [1 ]
Andruetto, P. [1 ]
Fanelli, V. [2 ]
Marra, W. Grosso [3 ]
Ranieri, M. V. [2 ]
Salizzoni, M. [1 ]
机构
[1] AO Citta Salute & Sci, Ctr Trapianto Fegato, Anestesia & Rianimaz 9, I-10126 Turin, Italy
[2] AO Citta Salute & Sci, Anestesia & Rianimaz 1, I-10126 Turin, Italy
[3] AO Citta Salute & Sci, Cardiol, I-10126 Turin, Italy
关键词
D O I
10.1016/j.transproceed.2013.07.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Portopulmonary hypertension has been reported in 2% to 9% of candidates for liver transplantation (OLT). If it is moderate to severe, it represents a contraindication to the procedure until pulmonary vasodilatative therapy has been optimized. We report the case of a 43-year-old man, scheduled for OLT due to alcoholic cirrhosis with hemosiderosis. His Model for End-Stage Liver Disease was 25 at that time. The preoperative evaluation showed a severe alteration of diffusion (pO(2) 68 mm Hg), without hepatopulmonary syndrome or portopulmonary hypertension (PPH) upon basal and dobutamine stress echocardiography. At the beginning of the OLT the hemodynamic profile showed mean pulmonary artery pressure (mPAP) 38 mm Hg, wedge pressure (WP) 19 mm Hg, cardiac output (CO) 9.1 L/min, pulmonary vascular resistance (PVR) 166 dyne s/cm(5), transpulmonary gradient ('TPG) 19 mm Hg, which lead us to promptly initiate inhaled nitric oxide (iNO) and intravenous epoprostenol 2 to 5 ng/kg/min. Upon graft reperfusion the hemodynamic profile was: mPAP 47 mm Hg, WP 23 mm Hg, CO 14.2 L/min, PVR 135 dyne s/cm(5), TPG 24 mm Hg, and at the end of surgery, mPAP 39 mm Hg, WP 20 mm Hg, CO 10.6 L/min, PVR 123 dyne s/cm(5), TPG 19 mm Hg. On postoperative day (POD) 3, we observed severe worsening of PPH: mPAP 60 mm Hg, WP 10 mm Hg, CO 9.8 L/min, PVR 395 dyne s/cm(5), TPG 50 mm Hg even with maximal pulmonary vasodilatatory therapy (ambrisentan 5 mg, intravenous sildenafil 20 mg x 3 and epoprostenol 22 ng/kg/min, iNO). Severe acute respiratory distress syndrome (ARDS) was presents. Therefore we decided to begin veno-venous extracorporeal membrane oxygenation (v-v ECMO) to correct the hypoxic vasoconstriction. Subsequent weaning from inotropic support with iNO and epoprostenol was possible on POD 7 due to mPAP 42 mm Hg, WP 15 mm Hg, CO 7.9 L/min, PVR 273 dyne s/cm(5), and TPG 27 mm Hg. On POD 11 he was weaned from ECMO due to: mPAP 40 mm Hg, WP 16 mm Hg, CO 6.5 L/min, PVR 295 dyne s/cm(5) and TPG 24 mm Hg. The patient was extubated on POD 17. The cardiac catheterization 1 month after OLT showed: mPAP 28 mm Hg, WP 13 mm Hg, CO 5.4 L/min, PVR 220 dyne s/cm(5) and TPG 15 mm Hg. ECMO rescue therapy in this "extreme" case allowed us to correct hypoxemia responsible for worsening of pulmonary hypertension allowing time to reach the goal of vasodilatatory therapy.
引用
收藏
页码:2774 / 2775
页数:2
相关论文
共 50 条
  • [1] Veno-arterial extracorporeal membrane oxygenation as an intraoperative rescue option in case of portopulmonary hypertension recognized during liver transplantation
    Martucci, Gennaro
    Burgio, Gaetano
    Lullo, Fabio
    Panarelo, Giovanna
    Arcadipane, Antonio
    MINERVA ANESTESIOLOGICA, 2017, 83 (12) : 1336 - 1337
  • [2] Extracorporeal membrane oxygenation and severe portopulmonary hypertension following liver transplantation: brief report
    Chan-Dominy, Amy C.
    Rahiman, Sarfaraz N.
    Anders, Marc
    Butt, Warwick
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2015, 38 (06): : 337 - 342
  • [3] Liver Transplantation Followed by Renal Transplantation on Extracorporeal Membrane Oxygenation: A Case Report
    Goswami, Shreya
    Ishag, Selma
    Hueneke, Rocco
    Lakshminarasimhachar, Anand
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (09) : 3107 - 3110
  • [4] Portopulmonary Hypertension after Liver Transplantation: A Case report
    Yun, S. P.
    Seo, H., I
    Yoon, M. H.
    TRANSPLANTATION, 2017, 101 (05) : 329 - 329
  • [5] PORTOPULMONARY HYPERTENSION AFTER LIVER TRANSPLANTATION: CASE REPORT
    Yun, Sung Pil
    Il Seo, Hyung
    Yoon, Myung Hee
    TRANSPLANT INTERNATIONAL, 2017, 30 : 507 - 507
  • [6] Planned Initiation of Venoarterial Extracorporeal Membrane Oxygenation Prior to Liver Transplantation in a Patient With Severe Portopulmonary Hypertension
    Barbas, Andrew S.
    Schroder, Jacob N.
    Borle, Deeplaxmi P.
    Suarez, Arturo
    Abraham, Nader
    Manning, Michael W.
    Miller, Timothy E.
    Berg, Carl L.
    Fortin, Terry A.
    Sudan, Debra L.
    Rege, Aparna S.
    LIVER TRANSPLANTATION, 2021, 27 (05) : 760 - 762
  • [7] Liver transplantation for severe portopulmonary hypertension: A case report and literature review
    Xiao-Jie Chen
    Zhi-Jun Zhu
    Li-Ying Sun
    Lin Wei
    Zhi-Gui Zeng
    Ying Liu
    Wei Qu
    Liang Zhang
    World Journal of Clinical Cases, 2019, 7 (21) : 3569 - 3574
  • [8] Liver transplantation for severe portopulmonary hypertension: A case report and literature review
    Chen, Xiao-Jie
    Zhu, Zhi-Jun
    Sun, Li-Ying
    Wei, Lin
    Zeng, Zhi-Gui
    Liu, Ying
    Qu, Wei
    Zhang, Liang
    WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (21) : 3569 - 3574
  • [9] Extracorporeal Membrane Oxygenation as a Rescue Device for Postreperfusion Cardiac Arrest During Liver Transplantation
    Tejani, Margaret
    Yi, Soo Youn
    Eudailey, Kyle W.
    George, Isaac
    Guarrera, James V.
    Wagener, Gebhard
    LIVER TRANSPLANTATION, 2015, 21 (03) : 410 - 414
  • [10] Perioperative Extracorporeal Membrane Oxygenation (ECMO) in Liver Transplantation: A Case Series
    Guorgui, J. G.
    Ito, T.
    Lu, M. M.
    Benharash, P.
    Ardehali, A.
    Gudzenko, V.
    Wray, C.
    Agopian, V. G.
    DiNorcia, J., III
    Yersiz, H.
    Farmer, D. G.
    Busuttil, R. W.
    Kaldas, F. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1124 - 1124